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The specific aim of this study is to determine the relationship between 
PDX-1 and HNF1B. Comparing these genes to each other and finding 
potential interactions may reveal essential components in recovering 
beta-cell function in those with Type I Diabetes.
• gRNA would not insert properly into the CRISPR-concatemer vector 
and therefore the gene knockout process would not be successful 
• Transfection of the pancreatic islets by means of electroporation 
would not be successful 
• Failure to quantify glucose responsiveness 
• After performing this double gene knockout, it is expected to see a 
significant decrease in beta-cell function and a low amount of 
quantified glucose responsiveness.
• If the study provides the expected results, a therapy derived from 
this study would open up lots of new doors for precision medicine 
and overall improve the quality of life of individuals with Type I 
Diabetes.  
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◀︎ Figure 3. Signal 
transduction pathway 
leading to the activation 
of PDX-1 causing insulin 
secretion.2
Split transgenic mice into 4 groups: 
control, single PDX-1 knockout, 
single HNF1β knockout, and double 
knockout 
Perform single and double gene 
knockouts of PDX-1 and PDX-
1/HNF1β using a CRISPR-
concatemer
Beta cell performance testing by 
quantifying the glucose 
responsiveness 
▼Figure 2. Deletion of 
HNF1β gene causes 
severe pancreatic 
hypoplasia and 
decrease in pancreatic 
weight.4
◀︎ Figure 1. 
Occurrence of Type I 
Diabetes in the United 
States.
• Diabetes Mellitus is characterized by uncontrolled and elevated blood 
glucose which is the effect of inadequate levels of plasma insulin.1
• Type I Diabetes ultimately stems from the autoimmune destruction of 
beta cells due to malfunction or lack of the PDX-1 gene.4
• The PDX-1 gene is necessary for pancreatic development including 
the maintenance and survival of β-cells which produce and secrete 
insulin.2
• The HNF1β gene is partially responsible for pancreatic development 
and lack of this gene can cause pancreatic hypoplasia.5
Figure 4. In comparison with a healthy pancreatic islet, a diabetic 
islet shows a depletion of beta-cells (violet) and therefore a loss of 
insulin secretion and ability to maintain target glucose levels.3
